Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Amit Trivedi, HIMSS director of informatics and health IT standards explains the human factor in interoperability is often overlooked. #HIMSS #HIMSS23

Health IT needs to develop its workforce and become more involved in setting informatics standards

Amit Trivedi, HIMSS director of informatics and health IT standards, explains the importance of the human role in interoperability.

1 in 3 physicians sued during career, with radiologists ‘significantly’ more likely to face litigation

Over 40% of radiologists said they’ve been sued during the course of their career, according to new survey data from the American Medical Association. 

American College of Radiology 2023 Annual Meeting

William Herrington elected ACR president, plus more news from the college’s 2023 annual meeting

Ezequiel Silva, MD, received the 2023 William T. Thorwarth Jr. Award, with several others recognized for their accomplishments.  

artificial intelligence warning united nations

Int’l panel: Safeguard human health against AI now—or risk losing the chance forever

As the world grapples with the potential downsides of generative AI, a global group of healthcare researchers is warning of health perils that could emanate from well beyond clinical settings.

The new MRI contrast agent gadopiclenol, sold under the trade names Elucirem and Vueway by Bracco and Guerbet, used 50% less gadolinium that current MRI agents. #RSNA22 #RSNA

New contrast agent earns positive safety classification from ACR

The ACR Committee on Drugs and Contrast Media stated that exposure to the gadolinium-based contrast agent represents a “sufficiently low or possibly nonexistent” risk to patients.

Researchers question FFR-CT’s value compared to other cardiac imaging options

FFR-CT has grown in popularity due its ability to provide noninvasive evaluations of patients being considered for revascularization procedures. According to a new study in JACC: Cardiovascular Imaging, however, stress imaging strategies may still provide more value in certain scenarios. 

FDA expands dapagliflozin approval to cover all heart failure patients

The FDA has previously approved the SGLT2 inhibitor in patients with HFrEF, but not HFmrEF or HFpEF

breast cancer screening mammography

USPSTF recommends women begin breast cancer screening at 40, boosting stocks at mammo-related firms

The draft update marks a shift from the task force's previous guidelines, which had endorsed screening beginning at age 50.